Angelini Pharma

Angelini is committed to identifying health solutions with a prevalent focus on the areas of Central Nervous System (CNS), including pain, and Rare Diseases. The Company is also a leading player in the Consumer Health sector,

News & pubblications

Core areas

  1. Rare Diseases

    A disease is defined as rare when its prevalence, that is the number of cases present at a given time in a given population, does not exceed a certain threshold. In the European Union this threshold is set at 0.05% of the population.

From Pipeline to health aids

  1. Pipeline

    The R&D mission is built on the dynamic pipelini concept, where each project can be partially or fully developed in-house or through collaborative partnership

  2. Sites

    All sites use the most advanced technologies, with automatic control and supervision systems. Analysis and quality control, right from the raw material stage, are particularly stringent.

Angelini Pharma Worldwide